Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study

Table 1 Neonatal blood glucose monitoring

Gestational age/Birth weight	Intravenous administration of RD	After birth	1 h after birth	3 h after birth
< 37 weeks or < 2500 g	+	〇	〇	〇
< 37 weeks or < 2500 g	–	〇	〇	〇
37 weeks ≤ and 2500 g ≤	+		〇	〇
37 weeks ≤ and 2500 g ≤	–			〇

RD Ritodrine hydrochloride
Neonatal blood glucose monitoring was carried out at the times indicated by circles in the table, according to the classification by gestational age, birth weight, and intravenous administration or non-administration of RD

ISSN: 2055-0294